查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
烟碱酰胺腺嘌呤二核苷酸的全球市场 (2022年～2030年):市场规模 (各等级、用途)、地区的展望、成长的潜在性、价格趋势、竞争市场占有率、预测
市场调查报告书
商品编码
1134408

烟碱酰胺腺嘌呤二核苷酸的全球市场 (2022年～2030年):市场规模 (各等级、用途)、地区的展望、成长的潜在性、价格趋势、竞争市场占有率、预测

Nicotinamide Adenine Dinucleotide Market Size By Grade, By Application, Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2022 - 2030
出版日期: | 出版商: Global Market Insights Inc. | 英文 250 Pages | 商品交期: 2-3个工作天内

价格

烟碱酰胺腺嘌呤二核苷酸的市场，随着全球美容标准的变化，预计至2030年大幅成长。

还有慢性疾病的剧增和製药产业的蓬勃发展，也推动在预测期间内的市场成长。

各等级中，由于有免疫力的提高和能源的供给，记忆力的改善，血压及胆固醇降低等优点，食品等级的部门从2022年到2030年显示可观的成长。

本报告提供全球烟碱酰胺腺嘌呤二核苷酸的市场调查，市场概要，市场成长的各种影响因素分析，法律制度，技术、革新的形势，专利趋势，市场规模的变化、预测，各种区分、各地区/主要国家的明细，竞争环境，主要企业简介等彙整资讯。

目录

第1章 调查手法、调查范围

第2章 摘要整理

第3章 烟碱酰胺腺嘌呤二核苷酸产业的考察

  • 产业的分类
  • 产业生态系统分析
  • 原料分析
  • 技术形势
    • 酵素流程
    • 化学流程
  • 法规情形
  • 各地区的价格趋势
  • 对产业的影响要素
    • 促进因素
    • 潜在的风险&课题
  • 革新、永续性
  • 成长性分析
  • 波特分析
  • PESTEL分析
  • COVID-19对市场的影响:各用途
  • 全球抗老化成分市场预测和抗老化疗法中NAD+所扮演的角色
  • COVID-19世界经济的影响
  • 俄罗斯、乌克兰战争对市场的影响

第4章 竞争情形

  • 企业的市场占有率
  • 主要企业的竞争分析
  • 供应商采用矩阵
  • 策略性展望矩阵

第5章 烟碱酰胺腺嘌呤二核苷酸市场:各等级

  • 主要趋势
  • 食品等级
  • 医药品等级
  • 其他

第6章 烟碱酰胺腺嘌呤二核苷酸市场:各用途

  • 主要趋势
  • 营养补充品
  • 医药品
  • 抗老化产品
  • 其他

第7章 烟碱酰胺腺嘌呤二核苷酸市场:各地区

  • 主要趋势
  • 北美
  • 欧洲
  • 亚太地区
  • 南美
  • 中东、非洲

第8章 企业简介

  • Bontac Bioengineering
  • Hefei Home Sunshine Pharmaceutical Technology Co., Ltd.
  • F. Hoffmann-La Roche Ltd
  • HiMedia Laboratories
  • NutriScience Innovations, LLC
  • Nutrifoods
  • Bontac Bio-engineering(shenzhen)Co.,Ltd
  • Krackeler Scientific
  • Shandong Lankang Bio-Technology Co., Ltd.
  • OYC Americas, Inc.
  • Xi'an Yinherb Bio-Tech Co., Ltd
  • Shenzhen Hygieia Biotechnology Co., Ltd
  • Zhejiang Dazhan Biotechnology Co., Ltd.
  • Otto Chemie Pvt. Ltd.
  • Uthever
Product Code: 5369

The nicotinamide adenine dinucleotide market is primed to grow massively through 2030 owing to shifting beauty standards across the world. In addition, burgeoning instances of chronic diseases, along with the thriving pharmaceutical industry, are likely to augment market growth over the forecast period.

The COVID-19 pandemic encouraged business owners to secure and sustain their supply networks in order to cater to rising product demand. However, advancements in NAD supplements and products, coupled with rising awareness pertaining to product benefits, bolstered product deployment in the cosmetics and pharmaceutical industries.

Moreover, key participants in the nicotinamide adenine dinucleotide market majorly engage in expanding the range of products and undertaking extensive R&D projects to remain ahead in the competitive landscape, thereby fuelling overall business growth. In October 2022, ChromaDex, a specialist in dietary supplements, published the results of a clinical study on the safety and tolerability of NAD+ precursor nicotinamide riboside (NR). The findings indicated that NR was able to raise NAD+ levels, emerging as a novel heart failure treatment with decreased ejection fraction.

The nicotinamide adenine dinucleotide market has been categorized on the basis of grade, application, and region.

Based on grade, the nicotinamide adenine dinucleotide industry has been divided into food grade, pharmaceutical grade, and others. The food-grade NAD segment is slated to amass substantial gains over 2022-2030 as a result of various advantages of NAD supplementation, such as increased immunity & energy, improved memory, and lower blood pressure & cholesterol.

With respect to application, the NAD market has been classified into dietary supplements, pharmaceuticals, anti-aging products, and others. The others application segment is poised to witness strong growth at over 11.5% CAGR by 2030. Other applications of NAD include its use as a biochemical assay, as a cofactor in research, and so on.

In in-vitro diagnostics, nicotinamide adenine dinucleotide is used for non-glucose target detection with the use of NAD dependent enzymes. Growing consumer awareness and acceptance of NAD-based products for analytical applications is speculated to accelerate the growth of the segment.

In the regional context, the Middle East & Africa NAD industry is anticipated to expand at more than 10% CAGR between 2022 and 2030. Enhanced food and beverage production, new technological developments, and the launch of innovative nutraceutical products in the MEA region are set to drive market progress.

Meanwhile, the Latin America nicotinamide adenine dinucleotide market is projected to depict over 10.5% CAGR over the next 8 years. Favorable foreign direct investments and trade policies in the pharmaceutical sector, together with advancements in the food & beverage industry, are foreseen to foster the LATAM nicotinamide adenine dinucleotide industry outlook.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market definitions
  • 1.2 Market parameters
  • 1.3 Forecast parameters & calculation

COVID 19 Impact Analysis

North America

Europe

Asia Pacific

LATAM

MEA

  • 1.4 Data Sources
    • 1.4.1 Primary
    • 1.4.2 Secondary
      • 1.4.2.1 Paid Sources
      • 1.4.2.2 Public Sources

Chapter 2 Executive Summary

  • 2.1 Global nicotinamide adenine dinucleotide industry 360 degree synopsis, 2022 - 2030
    • 2.1.1 Business trends
    • 2.1.2 Regional trends
    • 2.1.3 Grade trends
    • 2.1.4 Application trends

Chapter 3 Nicotinamide Adenine Dinucleotide Industry Insights

  • 3.1 Industry segmentation
  • 3.2 Industry ecosystem analysis
    • 3.2.1 Raw material suppliers
    • 3.2.2 Manufacturers
    • 3.2.3 End-use
    • 3.2.4 Distribution channel analysis
    • 3.2.5 Profit margin trends
    • 3.2.6 Vendor matrix
    • 3.2.7 Impact of COVID-19 on industry value chain
  • 3.3 Raw material analysis
  • 3.4 Technology landscape
    • 3.4.1 Enzymatic process
    • 3.4.2 Chemical process
  • 3.5 Regulatory landscape
    • 3.5.1 U.S
    • 3.5.2 Europe
    • 3.5.3 China
  • 3.6 Pricing trends, by region (2017 to 2030)
    • 3.6.1 Regional Pricing
      • 3.6.1.1 North America
      • 3.6.1.2 Europe
      • 3.6.1.3 Asia Pacific
      • 3.6.1.4 LATAM
      • 3.6.1.5 MEA
    • 3.6.2 COVID-19 impact on pricing trends
    • 3.6.3 Cost structure analysis, 2021
  • 3.7 Industry impact forces
    • 3.7.1 Growth drivers
      • 3.7.1.1 Growing utilization and demand from pharmaceutical industry
      • 3.7.1.2 The growing consumer demand for anti-aging products
    • 3.7.2 Industry pitfalls & challenges
      • 3.7.2.1 Stringent norms on the dosage use to prevent adverse health effects
  • 3.8 Innovation & sustainability
  • 3.9 Growth potential analysis, 2021
  • 3.10 Porter's analysis
  • 3.11 PESTEL analysis
  • 3.12 Impact of COVID-19 on nicotinamide adenine dinucleotide market, by application
    • 3.12.1 Dietary Supplements
    • 3.12.2 Pharmaceuticals
    • 3.12.3 Anti-aging Products
    • 3.12.4 Others
  • 3.13 Global anti-aging ingredients market outlook and the Role of NAD+ in anti-aging therapies
  • 3.14 Impact of covid-19 on world economy
  • 3.15 Impact of Russia-Ukraine war impact on nicotinamide adenine dinucleotide market

Chapter 4 Competitive Landscape, 2021

  • 4.1 Introduction
  • 4.2 Company market share, 2021
  • 4.3 Competitive analysis of major market players
  • 4.4 Vendor adoption matrix
  • 4.5 Strategic outlook matrix

Chapter 5 Nicotinamide Adenine Dinucleotide Market, By Grade

  • 5.1 Key grade trends
  • 5.2 Food Grade
    • 5.2.1 Market estimates and forecast, 2017 - 2030, (Tons) (USD Million)
    • 5.2.2 Market estimates and forecast, by region, 2017 - 2030, (Tons) (USD Million)
  • 5.3 Pharmaceutical Grade
    • 5.3.1 Market estimates and forecast, 2017 - 2030, (Tons) (USD Million)
    • 5.3.2 Market estimates and forecast, by region, 2017 - 2030, (Tons) (USD Million)
  • 5.4 Others
    • 5.4.1 Market estimates and forecast, 2017 - 2030, (Tons) (USD Million)
    • 5.4.2 Market estimates and forecast, by region, 2017 - 2030, (Tons) (USD Million)

Chapter 6 Nicotinamide Adenine Dinucleotide Market, By Application

  • 6.1 Key application trends
  • 6.2 Dietary Supplements
    • 6.2.1 Market estimates and forecast, 2017 - 2030, (Tons) (USD Million)
    • 6.2.2 Market estimates and forecast, by region, 2017 - 2030, (Tons) (USD Million)
  • 6.3 Pharmaceuticals
    • 6.3.1 Market estimates and forecast, 2017 - 2030, (Tons) (USD Million)
    • 6.3.2 Market estimates and forecast, by region, 2017 - 2030, (Tons) (USD Million)
  • 6.4 Anti-aging Products
    • 6.4.1 Market estimates and forecast, 2017 - 2030, (Tons) (USD Million)
    • 6.4.2 Market estimates and forecast, by region, 2017 - 2030, (Tons) (USD Million)
  • 6.5 Others
    • 6.5.1 Market estimates and forecast, 2017 - 2030, (Tons) (USD Million)
    • 6.5.2 Market estimates and forecast, by region, 2017 - 2030, (Tons) (USD Million)

Chapter 7 Nicotinamide Adenine Dinucleotide Market, By Region

  • 7.1 Key regional trends
  • 7.2 North America
    • 7.2.1 Market estimates and forecast, 2017 - 2030, (Tons) (USD Million)
    • 7.2.2 Market estimates and forecast, by grade, 2017 -2030, (Tons) (USD Million)
    • 7.2.3 Market estimates and forecast, by application, 2017 -2030, (Tons) (USD Million)
    • 7.2.4 U.S.
      • 7.2.4.1 Market estimates and forecast, 2017 - 2030, (Tons) (USD Million)
      • 7.2.4.2 Market estimates and forecast, by grade, 2017 -2030, (Tons) (USD Million)
      • 7.2.4.3 Market estimates and forecast, by application, 2017 -2030, (Tons) (USD Million)
    • 7.2.5 Canada
      • 7.2.5.1 Market estimates and forecast, 2017 - 2030, (Tons) (USD Million)
      • 7.2.5.2 Market estimates and forecast, by grade, 2017 -2030, (Tons) (USD Million)
      • 7.2.5.3 Market estimates and forecast, by application, 2017 -2030, (Tons) (USD Million)
  • 7.3 Europe
    • 7.3.1 Market estimates and forecast, 2017 - 2030, (Tons) (USD Million)
    • 7.3.2 Market estimates and forecast, by grade, 2017 -2030, (Tons) (USD Million)
    • 7.3.3 Market estimates and forecast, by application, 2017 -2030, (Tons) (USD Million)
    • 7.3.4 Germany
      • 7.3.4.1 Market estimates and forecast, 2017 - 2030, (Tons) (USD Million)
      • 7.3.4.2 Market estimates and forecast, by grade, 2017 -2030, (Tons) (USD Million)
      • 7.3.4.3 Market estimates and forecast, by application, 2017 -2030, (Tons) (USD Million)
    • 7.3.5 UK
      • 7.3.5.1 Market estimates and forecast, 2017 - 2030, (Tons) (USD Million)
      • 7.3.5.2 Market estimates and forecast, by grade, 2017 -2030, (Tons) (USD Million)
      • 7.3.5.3 Market estimates and forecast, by application, 2017 -2030, (Tons) (USD Million)
    • 7.3.6 France
      • 7.3.6.1 Market estimates and forecast, 2017 - 2030, (Tons) (USD Million)
      • 7.3.6.2 Market estimates and forecast, by grade, 2017 -2030, (Tons) (USD Million)
      • 7.3.6.3 Market estimates and forecast, by application, 2017 -2030, (Tons) (USD Million)
    • 7.3.7 Italy
      • 7.3.7.1 Market estimates and forecast, 2017 - 2030, (Tons) (USD Million)
      • 7.3.7.2 Market estimates and forecast, by grade, 2017 -2030, (Tons) (USD Million)
      • 7.3.7.3 Market estimates and forecast, by application, 2017 -2030, (Tons) (USD Million)
    • 7.3.8 Russia
      • 7.3.8.1 Market estimates and forecast, 2017 - 2030, (Tons) (USD Million)
      • 7.3.8.2 Market estimates and forecast, by grade, 2017 -2030, (Tons) (USD Million)
      • 7.3.8.3 Market estimates and forecast, by application, 2017 -2030, (Tons) (USD Million)
    • 7.3.9 Spain
      • 7.3.9.1 Market estimates and forecast, 2017 - 2030, (Tons) (USD Million)
      • 7.3.9.2 Market estimates and forecast, by grade, 2017 -2030, (Tons) (USD Million)
      • 7.3.9.3 Market estimates and forecast, by application, 2017 -2030, (Tons) (USD Million)
  • 7.4 Asia Pacific
    • 7.4.1 Market estimates and forecast, 2017 - 2030, (Tons) (USD Million)
    • 7.4.2 Market estimates and forecast, by grade, 2017 -2030, (Tons) (USD Million)
    • 7.4.3 Market estimates and forecast, by application, 2017 -2030, (Tons) (USD Million)
    • 7.4.4 China
      • 7.4.4.1 Market estimates and forecast, 2017 - 2030, (Tons) (USD Million)
      • 7.4.4.2 Market estimates and forecast, by grade, 2017 -2030, (Tons) (USD Million)
      • 7.4.4.3 Market estimates and forecast, by application, 2017 -2030, (Tons) (USD Million)
    • 7.4.5 India
      • 7.4.5.1 Market estimates and forecast, 2017 - 2030, (Tons) (USD Million)
      • 7.4.5.2 Market estimates and forecast, by grade, 2017 -2030, (Tons) (USD Million)
      • 7.4.5.3 Market estimates and forecast, by application, 2017 -2030, (Tons) (USD Million)
    • 7.4.6 Japan
      • 7.4.6.1 Market estimates and forecast, 2017 - 2030, (Tons) (USD Million)
      • 7.4.6.2 Market estimates and forecast, by grade, 2017 -2030, (Tons) (USD Million)
      • 7.4.6.3 Market estimates and forecast, by application, 2017 -2030, (Tons) (USD Million)
    • 7.4.7 South Korea
      • 7.4.7.1 Market estimates and forecast, 2017 - 2030, (Tons) (USD Million)
      • 7.4.7.2 Market estimates and forecast, by grade, 2017 -2030, (Tons) (USD Million)
      • 7.4.7.3 Market estimates and forecast, by application, 2017 -2030, (Tons) (USD Million)
    • 7.4.8 Australia
      • 7.4.8.1 Market estimates and forecast, 2017 - 2030, (Tons) (USD Million)
      • 7.4.8.2 Market estimates and forecast, by grade, 2017 -2030, (Tons) (USD Million)
      • 7.4.8.3 Market estimates and forecast, by application, 2017 -2030, (Tons) (USD Million)
  • 7.5 Latin America (LATAM)
    • 7.5.1 Market estimates and forecast, 2017 - 2030, (Tons) (USD Million)
    • 7.5.2 Market estimates and forecast, by grade, 2017 -2030, (Tons) (USD Million)
    • 7.5.3 Market estimates and forecast, by application, 2017 -2030, (Tons) (USD Million)
    • 7.5.4 Brazil
      • 7.5.4.1 Market estimates and forecast, 2017 - 2030, (Tons) (USD Million)
      • 7.5.4.2 Market estimates and forecast, by grade, 2017 -2030, (Tons) (USD Million)
      • 7.5.4.3 Market estimates and forecast, by application, 2017 -2030, (Tons) (USD Million)
    • 7.5.5 Argentina
      • 7.5.5.1 Market estimates and forecast, 2017 - 2030, (Tons) (USD Million)
      • 7.5.5.2 Market estimates and forecast, by grade, 2017 -2030, (Tons) (USD Million)
      • 7.5.5.3 Market estimates and forecast, by application, 2017 -2030, (Tons) (USD Million)
    • 7.5.6 Mexico
      • 7.5.6.1 Market estimates and forecast, 2017 - 2030, (Tons) (USD Million)
      • 7.5.6.2 Market estimates and forecast, by grade, 2017 -2030, (Tons) (USD Million)
      • 7.5.6.3 Market estimates and forecast, by application, 2017 -2030, (Tons) (USD Million)
  • 7.6 Middle East & Africa (MEA)
    • 7.6.1 Market estimates and forecast, 2017 - 2030, (Tons) (USD Million)
    • 7.6.2 Market estimates and forecast, by grade, 2017 -2030, (Tons) (USD Million)
    • 7.6.3 Market estimates and forecast, by application, 2017 -2030, (Tons) (USD Million)
    • 7.6.4 Saudi Arabia
      • 7.6.4.1 Market estimates and forecast, 2017 - 2030, (Tons) (USD Million)
      • 7.6.4.2 Market estimates and forecast, by grade, 2017 -2030, (Tons) (USD Million)
      • 7.6.4.3 Market estimates and forecast, by application, 2017 -2030, (Tons) (USD Million)
    • 7.6.5 UAE
      • 7.6.5.1 Market estimates and forecast, 2017 - 2030, (Tons) (USD Million)
      • 7.6.5.2 Market estimates and forecast, by grade, 2017 -2030, (Tons) (USD Million)
      • 7.6.5.3 Market estimates and forecast, by application, 2017 -2030, (Tons) (USD Million)
    • 7.6.6 South Africa
      • 7.6.6.1 Market estimates and forecast, 2017 - 2030, (Tons) (USD Million)
      • 7.6.6.2 Market estimates and forecast, by grade, 2017 -2030, (Tons) (USD Million)
      • 7.6.6.3 Market estimates and forecast, by application, 2017 -2030, (Tons) (USD Million)

Chapter 8 Company Profiles

  • 8.1 Bontac Bioengineering
    • 8.1.1 Business Overview
    • 8.1.2 Financial Data
    • 8.1.3 Product Landscape
    • 8.1.4 Strategic Outlook
    • 8.1.5 SWOT Analysis
  • 8.2 Hefei Home Sunshine Pharmaceutical Technology Co., Ltd.
    • 8.2.1 Business Overview
    • 8.2.2 Financial Data
    • 8.2.3 Product Landscape
    • 8.2.4 SWOT Analysis
    • 8.2.5 Strategic Outlook
  • 8.3 F. Hoffmann-La Roche Ltd
    • 8.3.1 Business Overview
    • 8.3.2 Financial Data
    • 8.3.3 Product Landscape
    • 8.3.4 Strategic Outlook
    • 8.3.5 SWOT Analysis
  • 8.4 HiMedia Laboratories
    • 8.4.1 Business Overview
    • 8.4.2 Financial Data
    • 8.4.3 Product Landscape
    • 8.4.4 Strategic Outlook
    • 8.4.5 SWOT Analysis
  • 8.5 NutriScience Innovations, LLC
    • 8.5.1 Business Overview
    • 8.5.2 Financial Data
    • 8.5.3 Product Landscape
    • 8.5.4 Strategic Outlook
    • 8.5.5 SWOT Analysis
  • 8.6 Nutrifoods
    • 8.6.1 Business Overview
    • 8.6.2 Financial Data
    • 8.6.3 Product Landscape
    • 8.6.4 Strategic Outlook
    • 8.6.5 SWOT Analysis
  • 8.7 Bontac Bio-engineering(shenzhen)Co.,Ltd
    • 8.7.1 Business Overview
    • 8.7.2 Financial Data
    • 8.7.3 Product Landscape
    • 8.7.4 Strategic Outlook
    • 8.7.5 SWOT Analysis
  • 8.8 Krackeler Scientific
    • 8.8.1 Business Overview
    • 8.8.2 Financial Data
    • 8.8.3 Product Landscape
    • 8.8.4 Strategic Outlook
    • 8.8.5 SWOT Analysis
  • 8.9 Shandong Lankang Bio-Technology Co., Ltd.
    • 8.9.1 Business Overview
    • 8.9.2 Financial Data
    • 8.9.3 Product Landscape
    • 8.9.4 Strategic Outlook
    • 8.9.5 SWOT Analysis
  • 8.10 OYC Americas, Inc.
    • 8.10.1 Business Overview
    • 8.10.2 Financial Data
    • 8.10.3 Product Landscape
    • 8.10.4 Strategic Outlook
    • 8.10.5 SWOT Analysis
  • 8.11 Xi'an Yinherb Bio-Tech Co., Ltd
    • 8.11.1 Business Overview
    • 8.11.2 Financial Data
    • 8.11.3 Product Landscape
    • 8.11.4 Strategic Outlook
    • 8.11.5 SWOT Analysis
  • 8.12 Shenzhen Hygieia Biotechnology Co., Ltd
    • 8.12.1 Business Overview
    • 8.12.2 Financial Data
    • 8.12.3 Product Landscape
    • 8.12.4 Strategic Outlook
    • 8.12.5 SWOT Analysis
  • 8.13 Zhejiang Dazhan Biotechnology Co., Ltd.
    • 8.13.1 Business Overview
    • 8.13.2 Financial Data
    • 8.13.3 Product Landscape
    • 8.13.4 Strategic Outlook
    • 8.13.5 SWOT Analysis
  • 8.14 Otto Chemie Pvt. Ltd.
    • 8.14.1 Business Overview
    • 8.14.2 Financial Data
    • 8.14.3 Product Landscape
    • 8.14.4 Strategic Outlook
    • 8.14.5 SWOT Analysis
  • 8.15 Uthever
    • 8.15.1 Business Overview
    • 8.15.2 Financial Data
    • 8.15.3 Product Landscape
    • 8.15.4 Strategic Outlook
    • 8.15.5 SWOT Analysis

Data Tables

  • Table 1 Global nicotinamide adenine dinucleotide market estimates and forecast, 2017 - 2030, (Tons) (USD Million)
  • Table 2 Global nicotinamide adenine dinucleotide market estimates and forecast, 2022 - 2030, (Tons) (USD Million)
  • Table 3 Global nicotinamide adenine dinucleotide market volume, by region, 2017 - 2030, (Tons)
  • Table 4 Global nicotinamide adenine dinucleotide market revenue, by region, 2017 - 2030, (USD Million)
  • Table 5 Global nicotinamide adenine dinucleotide market volume, by grade, 2017 - 2030, (Tons)
  • Table 6 Global nicotinamide adenine dinucleotide market revenue, by grade, 2017 - 2030, (USD Million)
  • Table 7 Global nicotinamide adenine dinucleotide market volume, by application, 2017 - 2030, (Tons)
  • Table 8 Global nicotinamide adenine dinucleotide market revenue, by application, 2017 - 2030, (USD Million)
  • Table 9 GDP growth (%) in 2020
  • Table 10 Real GDP growth (%) and projections from 2019 to 2022
  • Table 11 Vendor matrix
  • Table 12 Distribution channel analysis
  • Table 13 Industry impact forces
  • Table 14 Nicotinamide adenine dinucleotide market share, 2021
  • Table 15 Competitive analysis of major market players
  • Table 16 Global food grade nicotinamide adenine dinucleotide market estimates & forecast, 2017 - 2030, (Tons) (USD Million)
  • Table 17 Global food grade nicotinamide adenine dinucleotide market volume estimates & forecast, by region, 2017 - 2030, (Tons)
  • Table 18 Global food grade nicotinamide adenine dinucleotide market revenue estimates & forecast, by region, 2017 - 2030, (USD Million)
  • Table 19 Global pharmaceutical grade nicotinamide adenine dinucleotide market estimates & forecast, 2017 - 2030, (Tons) (USD Million)
  • Table 20 Global pharmaceutical grade nicotinamide adenine dinucleotide market volume estimates & forecast, by region, 2017 - 2030, (Tons)
  • Table 21 Global pharmaceutical grade nicotinamide adenine dinucleotide market revenue estimates & forecast, by region, 2017 - 2030, (USD Million)
  • Table 22 Global other grade nicotinamide adenine dinucleotide market estimates & forecast, 2017 - 2030, (Tons) (USD Million)
  • Table 23 Global other grade nicotinamide adenine dinucleotide market volume estimates & forecast, by region, 2017 - 2030, (Tons)
  • Table 24 Global other grade nicotinamide adenine dinucleotide market revenue estimates & forecast, by region, 2017 - 2030, (USD Million)
  • Table 25 Global nicotinamide adenine dinucleotide market for dietary supplements estimates & forecast, 2017 - 2030, (Tons) (USD Million)
  • Table 26 Global nicotinamide adenine dinucleotide market for dietary supplements volume estimates & forecast, by region, 2017 - 2030, (Tons)
  • Table 27 Global nicotinamide adenine dinucleotide market for dietary supplements revenue estimates & forecast, by region, 2017 - 2030, (USD Million)
  • Table 28 Global nicotinamide adenine dinucleotide market for pharmaceuticals estimates & forecast, 2017 - 2030, (Tons) (USD Million)
  • Table 29 Global nicotinamide adenine dinucleotide market for pharmaceuticals volume estimates & forecast, by region, 2017 - 2030, (Tons)
  • Table 30 Global nicotinamide adenine dinucleotide market for pharmaceuticals revenue estimates & forecast, by region, 2017 - 2030, (USD Million)
  • Table 31 Global nicotinamide adenine dinucleotide market for anti-aging products estimates & forecast, 2017 - 2030, (Tons) (USD Million)
  • Table 32 Global nicotinamide adenine dinucleotide market for anti-aging products volume estimates & forecast, by region, 2017 - 2030, (Tons)
  • Table 33 Global nicotinamide adenine dinucleotide market for anti-aging products revenue estimates & forecast, by region, 2017 - 2030, (USD Million)
  • Table 34 Global nicotinamide adenine dinucleotide market for other applications estimates & forecast, 2017 - 2030, (Tons) (USD Million)
  • Table 35 Global nicotinamide adenine dinucleotide market for other applications volume estimates & forecast, by region, 2017 - 2030, (Tons)
  • Table 36 Global nicotinamide adenine dinucleotide market for other applications revenue estimates & forecast, by region, 2017 - 2030, (USD Million)
  • Table 37 North America nicotinamide adenine dinucleotide market estimates & forecast, 2017 - 2030, (Tons) (USD Million)
  • Table 38 North America nicotinamide adenine dinucleotide market volume estimates & forecast, by grade, 2017 - 2030, (Tons)
  • Table 39 North America nicotinamide adenine dinucleotide market revenue estimates & forecast, by grade, 2017 - 2030, (USD Million)
  • Table 40 North America nicotinamide adenine dinucleotide market volume estimates & forecast, by application, 2017 - 2030, (Tons)
  • Table 41 North America nicotinamide adenine dinucleotide market revenue estimates & forecast, by application, 2017 - 2030, (USD Million)
  • Table 42 U.S. nicotinamide adenine dinucleotide market estimates & forecast, 2017 - 2030, (Tons) (USD Million)
  • Table 43 U.S. nicotinamide adenine dinucleotide market volume estimates & forecast, by grade, 2017 - 2030, (Tons)
  • Table 44 U.S. nicotinamide adenine dinucleotide market revenue estimates & forecast, by grade, 2017 - 2030, (USD Million)
  • Table 45 U.S. nicotinamide adenine dinucleotide market volume estimates & forecast, by application, 2017 - 2030, (Tons)
  • Table 46 U.S. nicotinamide adenine dinucleotide market revenue estimates & forecast, by application, 2017 - 2030, (USD Million)
  • Table 47 Canada nicotinamide adenine dinucleotide market estimates & forecast, 2017 - 2030, (Tons) (USD Million)
  • Table 48 Canada nicotinamide adenine dinucleotide market volume estimates & forecast, by grade, 2017 - 2030, (Tons)
  • Table 49 Canada nicotinamide adenine dinucleotide market revenue estimates & forecast, by grade, 2017 - 2030, (USD Million)
  • Table 50 Canada nicotinamide adenine dinucleotide market volume estimates & forecast, by application, 2017 - 2030, (Tons)
  • Table 51 Canada nicotinamide adenine dinucleotide market revenue estimates & forecast, by application, 2017 - 2030, (USD Million)
  • Table 52 Europe nicotinamide adenine dinucleotide market estimates & forecast, 2017 - 2030, (Tons) (USD Million)
  • Table 53 Europe nicotinamide adenine dinucleotide market volume estimates & forecast, by grade, 2017 - 2030, (Tons)
  • Table 54 Europe nicotinamide adenine dinucleotide market revenue estimates & forecast, by grade, 2017 - 2030, (USD Million)
  • Table 55 Europe nicotinamide adenine dinucleotide market volume estimates & forecast, by application, 2017 - 2030, (Tons)
  • Table 56 Europe nicotinamide adenine dinucleotide market revenue estimates & forecast, by application, 2017 - 2030, (USD Million)
  • Table 57 Germany nicotinamide adenine dinucleotide market estimates & forecast, 2017 - 2030, (Tons) (USD Million)
  • Table 58 Germany nicotinamide adenine dinucleotide market volume estimates & forecast, by grade, 2017 - 2030, (Tons)
  • Table 59 Germany nicotinamide adenine dinucleotide market revenue estimates & forecast, by grade, 2017 - 2030, (USD Million)
  • Table 60 Germany nicotinamide adenine dinucleotide market volume estimates & forecast, by application, 2017 - 2030, (Tons)
  • Table 61 Germany nicotinamide adenine dinucleotide market revenue estimates & forecast, by application, 2017 - 2030, (USD Million)
  • Table 62 UK nicotinamide adenine dinucleotide market estimates & forecast, 2017 - 2030, (Tons) (USD Million)
  • Table 63 UK nicotinamide adenine dinucleotide market volume estimates & forecast, by grade, 2017 - 2030, (Tons)
  • Table 64 UK nicotinamide adenine dinucleotide market revenue estimates & forecast, by grade, 2017 - 2030, (USD Million)
  • Table 65 UK nicotinamide adenine dinucleotide market volume estimates & forecast, by application, 2017 - 2030, (Tons)
  • Table 66 UK nicotinamide adenine dinucleotide market revenue estimates & forecast, by application, 2017 - 2030, (USD Million)
  • Table 67 France nicotinamide adenine dinucleotide market estimates & forecast, 2017 - 2030, (Tons) (USD Million)
  • Table 68 France nicotinamide adenine dinucleotide market volume estimates & forecast, by grade, 2017 - 2030, (Tons)
  • Table 69 France nicotinamide adenine dinucleotide market revenue estimates & forecast, by grade, 2017 - 2030, (USD Million)
  • Table 70 France nicotinamide adenine dinucleotide market volume estimates & forecast, by application, 2017 - 2030, (Tons)
  • Table 71 France nicotinamide adenine dinucleotide market revenue estimates & forecast, by application, 2017 - 2030, (USD Million)
  • Table 72 Italy nicotinamide adenine dinucleotide market estimates & forecast, 2017 - 2030, (Tons) (USD Million)
  • Table 73 Italy nicotinamide adenine dinucleotide market volume estimates & forecast, by grade, 2017 - 2030, (Tons)
  • Table 74 Italy nicotinamide adenine dinucleotide market revenue estimates & forecast, by grade, 2017 - 2030, (USD Million)
  • Table 75 Italy nicotinamide adenine dinucleotide market volume estimates & forecast, by application, 2017 - 2030, (Tons)
  • Table 76 Italy nicotinamide adenine dinucleotide market revenue estimates & forecast, by application, 2017 - 2030, (USD Million)
  • Table 77 Spain nicotinamide adenine dinucleotide market estimates & forecast, 2017 - 2030, (Tons) (USD Million)
  • Table 78 Spain nicotinamide adenine dinucleotide market volume estimates & forecast, by grade, 2017 - 2030, (Tons)
  • Table 79 Spain nicotinamide adenine dinucleotide market revenue estimates & forecast, by grade, 2017 - 2030, (USD Million)
  • Table 80 Spain nicotinamide adenine dinucleotide market volume estimates & forecast, by application, 2017 - 2030, (Tons)
  • Table 81 Spain nicotinamide adenine dinucleotide market revenue estimates & forecast, by application, 2017 - 2030, (USD Million)
  • Table 82 Russia nicotinamide adenine dinucleotide market estimates & forecast, 2017 - 2030, (Tons) (USD Million)
  • Table 83 Russia nicotinamide adenine dinucleotide market volume estimates & forecast, by grade, 2017 - 2030, (Tons)
  • Table 84 Russia nicotinamide adenine dinucleotide market revenue estimates & forecast, by grade, 2017 - 2030, (USD Million)
  • Table 85 Russia nicotinamide adenine dinucleotide market volume estimates & forecast, by application, 2017 - 2030, (Tons)
  • Table 86 Russia nicotinamide adenine dinucleotide market revenue estimates & forecast, by application, 2017 - 2030, (USD Million)
  • Table 87 APAC nicotinamide adenine dinucleotide market estimates & forecast, 2017 - 2030, (Tons) (USD Million)
  • Table 88 APAC nicotinamide adenine dinucleotide market volume estimates & forecast, by grade, 2017 - 2030, (Tons)
  • Table 89 APAC nicotinamide adenine dinucleotide market revenue estimates & forecast, by grade, 2017 - 2030, (USD Million)
  • Table 90 APAC nicotinamide adenine dinucleotide market volume estimates & forecast, by application, 2017 - 2030, (Tons)
  • Table 91 APAC nicotinamide adenine dinucleotide market revenue estimates & forecast, by application, 2017 - 2030, (USD Million)
  • Table 92 China nicotinamide adenine dinucleotide market estimates & forecast, 2017 - 2030, (Tons) (USD Million)
  • Table 93 China nicotinamide adenine dinucleotide market volume estimates & forecast, by grade, 2017 - 2030, (Tons)
  • Table 94 China nicotinamide adenine dinucleotide market revenue estimates & forecast, by grade, 2017 - 2030, (USD Million)
  • Table 95 China nicotinamide adenine dinucleotide market volume estimates & forecast, by application, 2017 - 2030, (Tons)
  • Table 96 China nicotinamide adenine dinucleotide market revenue estimates & forecast, by application, 2017 - 2030, (USD Million)
  • Table 97 Japan nicotinamide adenine dinucleotide market estimates & forecast, 2017 - 2030, (Tons) (USD Million)
  • Table 98 Japan nicotinamide adenine dinucleotide market volume estimates & forecast, by grade, 2017 - 2030, (Tons)
  • Table 99 Japan nicotinamide adenine dinucleotide market revenue estimates & forecast, by grade, 2017 - 2030, (USD Million)
  • Table 100 Japan nicotinamide adenine dinucleotide market volume estimates & forecast, by application, 2017 - 2030, (Tons)
  • Table 101 Japan nicotinamide adenine dinucleotide market revenue estimates & forecast, by application, 2017 - 2030, (USD Million)
  • Table 102 India nicotinamide adenine dinucleotide market estimates & forecast, 2017 - 2030, (Tons) (USD Million)
  • Table 103 India nicotinamide adenine dinucleotide market volume estimates & forecast, by grade, 2017 - 2030, (Tons)
  • Table 104 India nicotinamide adenine dinucleotide market revenue estimates & forecast, by grade, 2017 - 2030, (USD Million)
  • Table 105 India nicotinamide adenine dinucleotide market volume estimates & forecast, by application, 2017 - 2030, (Tons)
  • Table 106 India nicotinamide adenine dinucleotide market revenue estimates & forecast, by application, 2017 - 2030, (USD Million)
  • Table 107 South Korea nicotinamide adenine dinucleotide market estimates & forecast, 2017 - 2030, (Tons) (USD Million)
  • Table 108 South Korea nicotinamide adenine dinucleotide market volume estimates & forecast, by grade, 2017 - 2030, (Tons)
  • Table 109 South Korea nicotinamide adenine dinucleotide market revenue estimates & forecast, by grade, 2017 - 2030, (USD Million)
  • Table 110 South Korea nicotinamide adenine dinucleotide market volume estimates & forecast, by application, 2017 - 2030, (Tons)
  • Table 111 South Korea nicotinamide adenine dinucleotide market revenue estimates & forecast, by application, 2017 - 2030, (USD Million)
  • Table 112 Australia nicotinamide adenine dinucleotide market estimates & forecast, 2017 - 2030, (Tons) (USD Million)
  • Table 113 Australia nicotinamide adenine dinucleotide market volume estimates & forecast, by grade, 2017 - 2030, (Tons)
  • Table 114 Australia nicotinamide adenine dinucleotide market revenue estimates & forecast, by grade, 2017 - 2030, (USD Million)
  • Table 115 Australia nicotinamide adenine dinucleotide market volume estimates & forecast, by application, 2017 - 2030, (Tons)
  • Table 116 Australia nicotinamide adenine dinucleotide market revenue estimates & forecast, by application, 2017 - 2030, (USD Million)
  • Table 117 LATAM nicotinamide adenine dinucleotide market estimates & forecast, 2017 - 2030, (Tons) (USD Million)
  • Table 118 LATAM nicotinamide adenine dinucleotide market volume estimates & forecast, by grade, 2017 - 2030, (Tons)
  • Table 119 LATAM nicotinamide adenine dinucleotide market revenue estimates & forecast, by grade, 2017 - 2030, (USD Million)
  • Table 120 LATAM nicotinamide adenine dinucleotide market volume estimates & forecast, by application, 2017 - 2030, (Tons)
  • Table 121 LATAM nicotinamide adenine dinucleotide market revenue estimates & forecast, by application, 2017 - 2030, (USD Million)
  • Table 122 Brazil nicotinamide adenine dinucleotide market estimates & forecast, 2017 - 2030, (Tons) (USD Million)
  • Table 123 Brazil nicotinamide adenine dinucleotide market volume estimates & forecast, by grade, 2017 - 2030, (Tons)
  • Table 124 Brazil nicotinamide adenine dinucleotide market revenue estimates & forecast, by grade, 2017 - 2030, (USD Million)
  • Table 125 Brazil nicotinamide adenine dinucleotide market volume estimates & forecast, by application, 2017 - 2030, (Tons)
  • Table 126 Brazil nicotinamide adenine dinucleotide market revenue estimates & forecast, by application, 2017 - 2030, (USD Million)
  • Table 127 Mexico nicotinamide adenine dinucleotide market estimates & forecast, 2017 - 2030, (Tons) (USD Million)
  • Table 128 Mexico nicotinamide adenine dinucleotide market volume estimates & forecast, by grade, 2017 - 2030, (Tons)
  • Table 129 Mexico nicotinamide adenine dinucleotide market revenue estimates & forecast, by grade, 2017 - 2030, (USD Million)
  • Table 130 Mexico nicotinamide adenine dinucleotide market volume estimates & forecast, by application, 2017 - 2030, (Tons)
  • Table 131 Mexico nicotinamide adenine dinucleotide market revenue estimates & forecast, by application, 2017 - 2030, (USD Million)
  • Table 132 Argentina nicotinamide adenine dinucleotide market estimates & forecast, 2017 - 2030, (Tons) (USD Million)
  • Table 133 Argentina nicotinamide adenine dinucleotide market volume estimates & forecast, by grade, 2017 - 2030, (Tons)
  • Table 134 Argentina nicotinamide adenine dinucleotide market revenue estimates & forecast, by grade, 2017 - 2030, (USD Million)
  • Table 135 Argentina nicotinamide adenine dinucleotide market volume estimates & forecast, by application, 2017 - 2030, (Tons)
  • Table 136 Argentina nicotinamide adenine dinucleotide market revenue estimates & forecast, by application, 2017 - 2030, (USD Million)
  • Table 137 MEA nicotinamide adenine dinucleotide market estimates & forecast, 2017 - 2030, (Tons) (USD Million)
  • Table 138 MEA nicotinamide adenine dinucleotide market volume estimates & forecast, by grade, 2017 - 2030, (Tons)
  • Table 139 MEA nicotinamide adenine dinucleotide market revenue estimates & forecast, by grade, 2017 - 2030, (USD Million)
  • Table 140 MEA nicotinamide adenine dinucleotide market volume estimates & forecast, by application, 2017 - 2030, (Tons)
  • Table 141 MEA nicotinamide adenine dinucleotide market revenue estimates & forecast, by application, 2017 - 2030, (USD Million)
  • Table 142 Saudi Arabia nicotinamide adenine dinucleotide market estimates & forecast, 2017 - 2030, (Tons) (USD Million)
  • Table 143 Saudi Arabia nicotinamide adenine dinucleotide market volume estimates & forecast, by grade, 2017 - 2030, (Tons)
  • Table 144 Saudi Arabia nicotinamide adenine dinucleotide market revenue estimates & forecast, by grade, 2017 - 2030, (USD Million)
  • Table 145 Saudi Arabia nicotinamide adenine dinucleotide market volume estimates & forecast, by application, 2017 - 2030, (Tons)
  • Table 146 Saudi Arabia nicotinamide adenine dinucleotide market revenue estimates & forecast, by application, 2017 - 2030, (USD Million)
  • Table 147 UAE nicotinamide adenine dinucleotide market estimates & forecast, 2017 - 2030, (Tons) (USD Million)
  • Table 148 UAE nicotinamide adenine dinucleotide market volume estimates & forecast, by grade, 2017 - 2030, (Tons)
  • Table 149 UAE nicotinamide adenine dinucleotide market revenue estimates & forecast, by grade, 2017 - 2030, (USD Million)
  • Table 150 UAE nicotinamide adenine dinucleotide market volume estimates & forecast, by application, 2017 - 2030, (Tons)
  • Table 151 UAE nicotinamide adenine dinucleotide market revenue estimates & forecast, by application, 2017 - 2030, (USD Million)
  • Table 152 South Africa nicotinamide adenine dinucleotide market estimates & forecast, 2017 - 2030, (Tons) (USD Million)
  • Table 153 South Africa nicotinamide adenine dinucleotide market volume estimates & forecast, by grade, 2017 - 2030, (Tons)
  • Table 154 South Africa nicotinamide adenine dinucleotide market revenue estimates & forecast, by grade, 2017 - 2030, (USD Million)
  • Table 155 South Africa nicotinamide adenine dinucleotide market volume estimates & forecast, by application, 2017 - 2030, (Tons)
  • Table 156 South Africa nicotinamide adenine dinucleotide market revenue estimates & forecast, by application, 2017 - 2030, (USD Million)

Charts & Figures

  • FIG 1 Nicotinamide Adenine Dinucleotide 360 degree synopsis, 2022 - 2030
  • FIG 2 Industry segmentation
  • FIG 3 Industry ecosystem analysis
  • FIG 4 Growth potential analysis, 2021
  • FIG 5 Porter's analysis
  • FIG 6 PESTEL analysis
  • FIG 7 Company market share analysis, 2021
  • FIG 8 SWOT Analysis Bontac Bioengineering
  • FIG 9 SWOT Analysis, Hefei Home Sunshine Pharmaceutical Technology Co., Ltd.
  • FIG 10 SWOT Analysis, F. Hoffmann-La Roche Ltd
  • FIG 11 SWOT Analysis, HiMedia Laboratories
  • FIG 12 SWOT Analysis, NutriScience Innovations, LLC
  • FIG 13 SWOT Analysis, Nutrifoods
  • FIG 14 SWOT Analysis, Bontac Bio-engineering(shenzhen)co.,ltd
  • FIG 15 SWOT Analysis, Krackeler Scientific
  • FIG 16 SWOT Analysis, Shandong Lankang Bio-Technology Co., Ltd.
  • FIG 17 SWOT Analysis, OYC Americas, Inc.
  • FIG 18 SWOT Analysis, Xi'an Yinherb Bio-Tech Co., Ltd
  • FIG 19 SWOT Analysis, Shenzhen Hygieia Biotechnology Co., Ltd
  • FIG 20 SWOT Analysis, Zhejiang Dazhan Biotechnology Co., Ltd.
  • FIG 21 SWOT Analysis, Otto Chemie Pvt. Ltd.
  • FIG 22 SWOT Analysis, Uthever